Last 47 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -4.88 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 3.55 | 5.61 | 7.23 | 6.39 | 9.58 | 5.29 | 5.17 | 7.81 | 4.76 | 8.55 | 7.92 | 7.93 | 4.18 | 3.94 | 5.96 | 5.41 | 4.47 | 5.68 | 10.05 | 14.26 | 11.18 |
| — | +6.0% | +39.9% | -18.2% | +101.4% | -38.1% | -34.7% | -1.5% | +14.0% | +116.7% | +32.9% | +46.5% | -6.6% | -30.5% | -40.7% | -62.1% | -60.0% | -71.8% | -31.3% | +2.0% | +46.0% | |
| P/B Ratio | 5.30 | 9.84 | 9.28 | 11.79 | 24.81 | 27.59 | 18.89 | 17.32 | 10.79 | 9.18 | 10.88 | 6.60 | 5.36 | 4.60 | 5.33 | 4.95 | 4.11 | 3.93 | 7.47 | 11.92 | 10.14 |
| — | -64.3% | -50.9% | -31.9% | +129.9% | +200.5% | +73.7% | +162.3% | +101.2% | +99.7% | +104.2% | +33.5% | +30.6% | +16.9% | -28.6% | -58.5% | -59.5% | -77.3% | -40.4% | +25.7% | +54.5% | |
| P/FCF | — | — | — | — | — | — | — | 39.16 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 52.7% | 58.5% | 60.3% | 50.1% | 54.9% | 52.0% | 54.4% | 50.7% | 44.6% | 73.6% | 57.6% | 60.0% | 52.0% | 53.3% | 59.2% | 59.0% | 59.6% | 75.9% | 70.0% | 72.2% | 52.0% |
| — | +12.4% | +10.9% | -1.3% | +23.3% | -29.3% | -5.6% | -15.4% | -14.4% | +38.1% | -2.6% | +1.6% | -12.7% | -29.8% | -15.4% | -18.3% | +14.7% | +5.2% | +0.3% | -5.6% | -3.3% | |
| Operating Margin | -68.3% | -59.6% | -82.4% | -65.4% | -87.8% | -45.2% | -79.3% | -120.3% | -69.0% | -133.7% | -69.0% | -116.2% | -72.3% | -67.1% | -85.8% | -61.0% | -66.0% | -84.2% | -58.1% | -40.7% | -50.7% |
| — | -31.8% | -3.8% | +45.7% | -27.3% | +66.2% | -15.0% | -3.5% | +4.6% | -99.2% | +19.6% | -90.4% | -9.6% | +20.2% | -47.7% | -50.1% | -30.0% | -124.7% | -227.9% | -135.8% | -182.5% | |
| Net Margin | -66.8% | -58.3% | -93.2% | -64.0% | -86.6% | -43.5% | -77.9% | -118.5% | -67.3% | -129.6% | -65.5% | -110.4% | -68.8% | -63.1% | -81.7% | -56.9% | -64.2% | -83.5% | -58.1% | -40.7% | -50.7% |
| — | -34.0% | -19.5% | +46.0% | -28.6% | +66.4% | -19.0% | -7.4% | +2.2% | -105.4% | +19.8% | -94.0% | -7.2% | +24.4% | -40.6% | -39.8% | -26.6% | -523.7% | -226.8% | -135.3% | -180.7% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -143.6% | -24.1% | -30.6% | -36.6% | -70.7% | -51.3% | -59.4% | -54.3% | -37.5% | -31.7% | -21.5% | -21.8% | -20.9% | -17.6% | -17.5% | -12.7% | -14.3% | -14.0% | -10.6% | -8.4% | -11.2% |
| — | +53.0% | +48.5% | +32.7% | -88.4% | -61.7% | -176.4% | -149.2% | -79.2% | -79.9% | -23.0% | -71.4% | -46.7% | -26.0% | -65.3% | -51.0% | -27.0% | -375.7% | -177.9% | -188.6% | -192.9% | |
| ROA | -43.7% | -8.2% | -11.0% | -11.3% | -14.9% | -8.8% | -12.6% | -15.4% | -14.2% | -15.5% | -11.1% | -11.7% | -11.6% | -10.0% | -10.3% | -7.6% | -8.7% | -9.0% | -6.9% | -5.5% | -7.7% |
| — | +7.4% | +12.5% | +26.5% | -4.6% | +43.0% | -13.7% | -32.0% | -23.1% | -54.4% | -7.9% | -53.7% | -32.6% | -11.3% | -48.8% | -39.0% | -12.6% | -331.5% | -157.4% | -160.2% | -181.2% | |
| ROIC | -207.9% | -30.6% | -37.0% | -48.8% | -81.1% | -66.6% | -102.6% | -67.6% | -49.9% | -59.6% | -46.3% | -51.7% | -48.2% | -20.2% | -14.4% | -17.8% | -46.3% | -46.0% | -39.2% | -37.8% | -90.7% |
| — | +54.1% | +63.9% | +27.8% | -62.4% | -11.7% | -121.7% | -30.7% | -3.7% | -195.4% | -222.1% | -190.8% | -4.1% | +56.1% | +63.3% | +53.0% | +49.0% | +73.3% | +56.8% | +41.4% | -87.5% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.29 | 0.30 | 0.27 | 0.29 | 0.48 | 0.85 | 0.72 | 0.53 | 0.38 | 0.32 | 0.27 | 0.25 | 0.23 | 0.21 | 0.20 | 0.18 | 0.18 | 0.17 | 0.16 | 0.15 | 0.16 |
| — | -65.1% | -62.5% | -44.7% | +28.0% | +169.3% | +166.8% | +109.8% | +64.5% | +49.5% | +36.5% | +36.4% | +29.0% | +24.9% | +23.4% | +18.4% | +9.0% | +506.3% | +65.5% | +40.2% | +33.5% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 1.51 | 1.42 | 1.55 | 1.51 | 1.31 | 1.06 | 1.07 | 1.22 | 1.39 | 2.29 | 2.43 | 2.51 | 2.73 | 2.70 | 2.87 | 3.03 | 2.96 | 3.42 | 4.10 | 3.87 | 3.86 |
| — | +34.3% | +45.1% | +23.7% | -5.9% | -53.9% | -56.0% | -51.3% | -49.0% | -15.3% | -15.3% | -17.0% | -8.0% | -20.8% | -30.1% | -21.9% | -23.2% | -16.9% | +21.1% | -0.2% | -3.7% | |
| Quick Ratio | 1.09 | 0.95 | 1.10 | 1.09 | 0.81 | 0.59 | 0.66 | 0.84 | 0.96 | 1.53 | 1.79 | 1.88 | 2.20 | 2.17 | 2.27 | 2.47 | 2.44 | 2.85 | 3.68 | 3.54 | 3.58 |
| — | +60.4% | +65.1% | +29.5% | -15.2% | -61.4% | -62.8% | -55.3% | -56.6% | -29.3% | -21.3% | -24.2% | -9.6% | -23.8% | -38.3% | -30.1% | -31.9% | -25.2% | +15.8% | -2.8% | -5.7% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -746.72 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying STXS stock.
Stereotaxis, Inc.'s current P/E is -4.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Stereotaxis, Inc.'s current operating margin is -68.3%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Stereotaxis, Inc.'s business trajectory between earnings reports.